Search clinical trials for: FDG positron emission tomography (FDG PET)

Total 8660 results

University of Cincinnati

Active, not recruiting

Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging

PET Imaging

United States
GE Healthcare

Terminated

Development of an Integrated Positron Emission Tomography/Magnetic Resonance (PET/MR) System, Accessories and Components

Indication for a PET CT Exam

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification

Positron Emission Tomography-Magnetic Resonance (PET-MR)

United States
Centre Hospitalier Universitaire Dijon

Recruiting

Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis (FIPOXY)

Idiopathic Pulmonary Fibrosis

France
Washington University School of Medicine
National Cancer Institute (NCI)

Terminated

Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

PET/CT

United States
Sheba Medical Center
Computational Imaging Lab , Dr. Arnaldo Mayer

Unknown

Positron Emission Tomography (PET) Images Using Deep Neural Networks

PET Images and Deep Neural Networks Algorithms

Israel
SmartNuclide Biopharma
The First Affiliated Hospital of Soochow University

Recruiting

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Solid Tumor | Positron-Emission Tomography(PET)

China
Turku University Hospital

Recruiting

Brain Insulin Resistance in Mild Cognitive Impairment (COINS)

Alzheimer Disease | Mild Cognitive Impairment | Positron Emission Tomography

Finland
SmartNuclide Biopharma

Recruiting

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Solid Tumor | Positron-Emission Tomography(PET)

China
University Hospital, Essen

Completed

FAPI PET/CT Prospective Interobserver Agreement (AGREE-FAPI)

Malignant Neoplasm

Germany
Rigshospitalet, Denmark
Danish Cancer Society; Danish Centre for Health Technology Assessment

Completed

Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer

Non-Small Cell Lung Cancer | Thoracotomy

Denmark
Yale University
VA Office of Research and Development

Recruiting

Examination of Glutamate and mGluR5 in Psychiatric Disorders

Bipolar Disorder | Major Depressive Disorder | Post-Traumatic Stress Disorder

United States
University of Manitoba
Winnipeg Regional Health Authority

Unknown

18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology

Tumors

Canada
Ontario Clinical Oncology Group (OCOG)

Completed

Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy (IMPACT)

Locally Advanced Breast Cancer (LABC)

Canada
Centre Georges Francois Leclerc

Active, not recruiting

Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer (TREN)

FDG PET

France
Turku University Hospital

Recruiting

Exercise and Tumor Blood Flow (EXETUMOR)

Tumor Blood Flow at Rest and During Exercise

Finland
Bristol-Myers Squibb

Completed

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers

Immunology

United States
University of Turku
Academy of Finland; Hospital District of Southwestern Finland

Completed

The Neural Mechanisms of Anesthesia and Human Consciousness (LOC-2013)

Consciousness, Level Altered

Finland
University of Cincinnati
National Cancer Institute (NCI); Ohio Third Frontier

Active, not recruiting

Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT

PET/CT Imaging

United States
Zhongnan Hospital

Recruiting

68Ga-FAPI PET/CT in Malignant Tumors

Malignant Neoplasm | PET/CT | Fibroblast Activation Protein Inhibitor

China
National Taiwan University Hospital

Unknown

Application of Integrated MR-PET in Patients With Gynecologic Cancers

MR-PET Imaging

Taiwan
Yale University
National Cancer Institute (NCI)

Terminated

Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases

Cancer Head Neck | Metastatic Cancer | Metastatic Lung Cancer

United States
Taisho Pharmaceutical R&D Inc.
Yale University

Completed

Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male Subjects

Healthy

United States
Centre Georges Francois Leclerc

Terminated

Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib (PREMETHEP)

Carcinoma, Hepatocellular

France
Institut Bergonié

Completed

Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy (APOGEE)

Hypermetabolic Lymphadenopathy Mediastinum Lower, Posterior and Middle, Detected by PET-CT With 18F-FDG (PET)

France
Turku University Hospital

Completed

Longitudinal Follow-up of Brown Adipose Tissue Function and Structure (BATFollowUp)

Obesity

Finland
University of Wisconsin, Madison

Recruiting

PET/CT Characterization of Treatment Resistance

Prostate Cancer

United States
Royal Marsden NHS Foundation Trust
City, University of London

Unknown

Radiation Exposure Awareness From Patients Undergoing Nuclear Medicine Diagnostic Scans (REA)

FDG PET/CT | Skeletal Scintigraphy

United Kingdom
Rigshospitalet, Denmark

Unknown

uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

Urinary Bladder Neoplasms

Denmark
Assistance Publique - Hôpitaux de Paris

Completed

Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized Study (ITEP)

Colorectal Cancer

France
National Institute of Mental Health (NIMH)

Completed

PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

Healthy | PET Scan | Glutamate Receptor | mGlur5 Protein | Excitatory Amino Acid Receptors | Drug Kinetics

United States
University of Aarhus
Lundbeck Foundation

Completed

Parkinson's Disease Evaluated by PET and the Effect of Memantine

Parkinson's Disease

Denmark
Turku University Hospital
University of Turku; Kuopio University Hospital; University of Eastern Finland

Recruiting

Variation of Genes Controlling Carbohydrate and Lipid Metabolism (CMgene)

Cardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Insulin Resistance | PreDiabetes | Lipid Metabolism Disorders

Finland
Region Västerbotten
Umeå University

Recruiting

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) (PRODIGYN)

Cervix Cancer | Endometrial Cancer | Epithelial Ovarian Cancer

Sweden
YiHui Guan

Recruiting

Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer

Pancreatic Neoplasms | Positron Emission Tomography | Igestive System Neoplasms

China
Cerevel Therapeutics, LLC

Recruiting

Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing

Opioid Use Disorder

United States
Turku University Hospital

Active, not recruiting

Effects of Morbid Obesity and Bariatric Surgery on Brain Inflammation, and Activation of Central Reward System (BARIBRAIN)

Morbid Obesity

Finland
Abdul Latif Jameel Poverty Action Lab
Massachusetts Institute of Technology; Aurora Health Care; Laura and John Arnold...

Completed

Clinical Decision Support (CDS) for Radiology Imaging

CT, MR, NM, and PET Image Orders

United States
Rigshospitalet, Denmark

Not yet recruiting

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease

Chronic Ischemic Heart Disease

Denmark
Yale University
Pfizer; Avid Radiopharmaceuticals

Completed

Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients

Diabetes Mellitus, Type 1

United States
Sir Mortimer B. Davis - Jewish General Hospital

Enrolling by invitation

Fluorocholine PET/CT Basket Trial

Fluorocholine PET/CT

Canada
GE Healthcare

Completed

Comparison of 18F FDG PET/CT TO PET MRI (PET/MR US)

Any Condition With a Clinical Indication for PET/CT Exam

United States
Assiut University

Not yet recruiting

Kidney Uptake at F-18 FDG PET/CT Studies and Renal Function Status

Renal Uptake at F-18-FDG PET/CT
GE Healthcare

Completed

Clinical Evaluation of an Integrated PET/MRI System (PET/MR_ZURICH)

Subjects With Clinical Indication for PET/CT

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System (ULD-PET)

PET/CT

Switzerland
University of Utah
National Cancer Institute (NCI)

Completed

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

Venothromboembolism

United States
Washington University School of Medicine
Siemens Corporation, Corporate Technology

Terminated

Gated and Non-Gated Dynamic PET/CT Imaging

Dynamic PET/CT Imaging

United States
Rigshospitalet, Denmark

Completed

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis

Acute Myocardial Infarction

Denmark
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand

Hypoglycemia

United States
Rigshospitalet, Denmark

Completed

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Neuroendocrine Tumors

Denmark

Search clinical trials for: FDG positron emission tomography (FDG PET)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations